The Model for Endstage Liver Disease MELD Score is Predictive of ICU Mortality in Patients with Cirr - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

The Model for Endstage Liver Disease MELD Score is Predictive of ICU Mortality in Patients with Cirr

Description:

those who received a LT during their index hospitalization. Methods ... Deaths and Hospitalizations from Chronic Liver Disease and Cirrhosis -- United ... – PowerPoint PPT presentation

Number of Views:503
Avg rating:3.0/5.0
Slides: 34
Provided by: ellakr
Category:

less

Transcript and Presenter's Notes

Title: The Model for Endstage Liver Disease MELD Score is Predictive of ICU Mortality in Patients with Cirr


1
The Model for End-stage Liver Disease (MELD)
Score is Predictive of ICU Mortality in Patients
with Cirrhosis
  • Ali Massoumi, MD
  • Division of Internal Medicine, Georgetown
    University Hospital

2
Background
  • Chronic liver disease, including cirrhosis
    remains one of the major causes of death in the
    United States
  • Based on CDC results, it is the ninth leading
    cause of death and one of the major causes of
    hospitalization
  • Cirrhotics admitted to the ICU have been shown to
    have poor prognosis with a high rate of mortality

3
Background
  • Prognostic models have been developed as a means
    of estimating the survival based on disease
    severity
  • Often these models incorporate various critical
    laboratory values to compute scores with their
    respective prognostic scores
  • Of these models, the Acute Physiology and Chronic
    Health Evaluation System (APACHE) has now become
    one of the standard indicators of prognosis of
    patients admitted to the intensive care unit
    (ICU) regardless of disease state

4
Background
  • APACHE II includes underlying diseases and
    chronic health status, however it has been
    criticized as its mortality predictions have been
    less than observed.
  • While the APACHE II scores can be used as a
    general prognostic model, few groups have
    investigated the role specific markers for
    cirrhotics admitted to the ICU
  • Furthermore, APACHE II cannot accurately predict
    outcome for specific patient subgroups, such as
    liver failure

5
APACHE II Requirements
  • Temp / MAP / HR / RR / A-a gradient
  • PaO2 / HCO3/ pH / Na
  • GCS / Creatinine / K
  • Hct / Age / WBC
  • Presence of chronic disease (e.g. COPD, class IV
    HF, portal hypertension)

6
Background
  • Other models are more disease specific, as is
    the case for Model for End-Stage Liver Disease
    (MELD)
  • MELD scores were developed to determine the
    severity of liver disease based on the patients
    serum bilirubin, serum creatinine, and the
    international normalized ration (INR)
  • MELD Score 10 0.957 Ln(Serum creatinine mg/dL)
    0.378 Ln(Total bilirubin mg/dL) 1.12 Ln(INR)
    0.643.

7
Background
  • The MELD score is currently a well accepted
    scoring system of chronic liver disease in order
    to predict survival
  • The score is then used by the UNOS (United
    Network of Organ Sharing) in the allocation of
    livers for transplantation
  • 3 month mortality If MELD lt 9? lt2 MELD
    gt40?71
  • Although the MELD is now the accepted criteria
    for determining prognosis of overall mortality,
    we found no studies using the MELD score as an
    indicator of survival in the ICU for those not
    eligible for a transplant

8
Background
  • Aggarwal et al evaluated cirrhotic patients
    admitted to the ICU in order to determine
    independent risk factors for prognosis
  • The group found an overall MICU mortality of
    36.6, with independent predictors of mortality
    in the MICU found to be an APACHE III score gt90,
    the use of mechanical ventilation, and
    vasopressors
  • Child-Pugh score has not been shown to be an
    independent predictive of mortality in the ICU

9
Background
  • Intensive care unit (ICU) admission is associated
    with a high mortality rate in those with
    cirrhosis
  • ICU specific prognostic scores are derived from
    analyses comprising of few cirrhotic patients,
    and thus may not be generalizable to this patient
    population

10
Goals of Study
  • Compare the model for end stage liver disease
    (MELD) to the Acute Physiology and Chronic Health
    Evaluation II (APACHE II) score in predicting
    mortality.
  • Define predictors of mortality in a cohort of
    cirrhotics admitted to an ICU

11
Methods
  • We proceeded with a retrospective chart review
    of cirrhotic patients admitted to the Georgetown
    University ICU (SICU or MICU) over the span of
    seven years (1998-2005).
  • Attention was paid to
  • MELD score upon admission
  • Interventions implemented during the ICU course
  • Need for vasopressors or mechanical ventilation
  • Presence of co-morbidities (cardiac disease,
    malignancies, renal failure)
  • Patient outcome (death, withdrawal of care,
    discharge from the ICU).

12
Methods
  • We excluded the following patients
  • under the age of 18
  • those with acute liver failure
  • prior liver transplant (LT)
  • those who received a LT during their index
    hospitalization

13
Methods
  • Multivariate logistic regression was performed
    to evaluate admission factors associated with
    survival.
  • The MELD and APACHE II scores were compared by
    the area under receiver operating characteristic
    curves (AUROC).

14
Results
  • A total of 322 patients were initially screened.
    104 patients were studied, of whom 65 were male,
    and 32 had Hepatitis C
  • The principal indication for ICU admission was
    gastrointestinal bleeding (34) and the majority
    of patients (71) had renal failure

15
Etiology of Cirrhosis
16
Admitting Diagnosis
17
Results
  • Nineteen percent of patients did not survive the
    ICU admission, and a further 50 were withdrawn
    from intensive care based on perceived futility.
  • This resulted in an overall survival rate of 31.

18
Outcome
19
Variables During ICU Course
20
Results
  • Of those that did not survive, the average MELD
    score was 25 compared to 21 in those who survived
    (p0.02)
  • The MELD score was shown to be an independent
    predictor of mortality (OR 0.824 95 CI,
    0.761-0.893 Plt0.0001)

21
(No Transcript)
22
Results
  • Of those that did not survive, the average APACHE
    II score was 21, compared to 11 to those who did
    survive
  • The APACHE II score was shown to be an
    independent predictor of mortality (OR 0.789 95
    CI, 0.715-0.871 Plt0.0001),

23
(No Transcript)
24
(No Transcript)
25
MELD vs APACHE II
  • MELD score was shown to be superior to the APACHE
    II score
  • (AU-ROC 0.82 vs 0.71, respectively)

26
Results
  • MELD score vs Survival after adjusting for other
    variables
  • Including etiology, age, sex, sepsis, ARF,
    pressors, admitting dx, co-morbidity,
    interventions
  • The probability of survival is related to the
    collection of variables (Plt0.0001)
  • However, adjusting for individual predictors, the
    MELD was not predictive of survival (OR1.027,
    95 CI 0.855-1.233, P 0.8197

27
Results
  • On multivariate analysis, co-morbidity and MELD
    score gt30 were found to be predictive of
    non-survival.
  • Co-morbidity OR0.884, 95 CI 0.787-0.993, P
    0.0374
  • Co-morbidity was defined as CAD, malignancies, or
    history of renal failure

28
Limitations / Future Goals
  • Mortality in the ICU can be multi-factorial
  • Increase sample size
  • To further evaluate the role of individual
    predictors in relation to the MELD score
  • Expand comparison to other models such as APACHE
    III and SOFA (sequential organ failure assessment
    ) score
  • An increase in the SOFA score within the first 48
    hours has been shown to be a poor predictor
  • Incorporates bili, MAP, creatinine, GCS,
    respiratory evaluation, platelets

29
Conclusions
  • Our study indicates that the admission MELD score
    in cirrhotics is an independent prognostic
    indicator of ICU mortality, and is superior to
    the more cumbersome model such as the APACHE II

30
Conclusions
  • Patients with a MELD score exceeding 30, with
    co-morbid illness, are unlikely to survive their
    ICU admission

31
Conclusions
  • It is hoped that delineation of a subgroup in
    whom specialized therapies are futile will
    optimize utilization of interventions in patients
    who will derive maximal benefit from such care.

32
Acknowledgements
  • Kirti Shetty, MD¹
  • Muhannad Hafi
  • Amy Lu, MD¹
  • Lynt B. Johnson, MD¹
  • ¹Division of Transplantation, Georgetown
    University Hospital

33
References
  • Deaths and Hospitalizations from Chronic Liver
    Disease and Cirrhosis -- United States, 1980-1989
    CDC Vital and Health Statistics Series. January
    08, 1993 / 41(52)969-973
  • Predictors of Mortality and Resource Utilization
    in Cirrhotic Patients Admitted to the Medical ICU
    Anjana Aggarwal
  • Pugh RN et al.Transection of the oesophagus for
    bleeding oesophagus varices. Br J Surg.
    1973.60646-649
  • Outcome of patients with cirrhosis requiring
    intensive care unit support prospective
    assessment of predictors of mortality. Singh N,
    Gavoski T, Wagener MM, Manno IR
  • Predictors of long-term mortality in patients
    with cirrhosis of the liver admitted to a medical
    ICU. Gildea TR, Cook WC, Nelson DR, Aggarwal A,
    Carey W, Younossi ZM, Arroliga AC. Chest. 2004
    Nov126(5)1598-603
Write a Comment
User Comments (0)
About PowerShow.com